These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 9067927

  • 1. Correspondence between stone composition and urine supersaturation in nephrolithiasis.
    Parks JH, Coward M, Coe FL.
    Kidney Int; 1997 Mar; 51(3):894-900. PubMed ID: 9067927
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA.
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Supersaturation and stone composition in a network of dispersed treatment sites.
    Asplin J, Parks J, Lingeman J, Kahnoski R, Mardis H, Lacey S, Goldfarb D, Grasso M, Coe F.
    J Urol; 1998 Jun; 159(6):1821-5. PubMed ID: 9598467
    [Abstract] [Full Text] [Related]

  • 7. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
    Tiselius HG.
    Urol Res; 1997 Jun; 25(2):153-9. PubMed ID: 9144885
    [Abstract] [Full Text] [Related]

  • 8. Divergence between stone composition and urine supersaturation: clinical and laboratory implications.
    Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, Asplin JR, Parks JH, Coe FL.
    J Urol; 1999 Apr; 161(4):1077-81. PubMed ID: 10081841
    [Abstract] [Full Text] [Related]

  • 9. [Correlations between crystalluria and composition of calculi].
    Kaid-Omar Z, Daudon M, Attar A, Semmoud A, Lacour B, Addou A.
    Prog Urol; 1999 Sep; 9(4):633-41. PubMed ID: 10555214
    [Abstract] [Full Text] [Related]

  • 10. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time.
    Parks JH, Coe FL, Evan AP, Worcester EM.
    Nephrol Dial Transplant; 2009 Jan; 24(1):130-6. PubMed ID: 18662977
    [Abstract] [Full Text] [Related]

  • 11. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ, Bozorgmehri S, Kuo J, Canales M, Bird VG, Canales B.
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [Abstract] [Full Text] [Related]

  • 12. Essential arterial hypertension and stone disease.
    Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A.
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Supersaturation Outputs from Different Programs and Their Application in Testing Correspondence with Kidney Stone Composition.
    Rodriguez A, Cunha TDS, Rodgers AL, Gambaro G, Ferraro PM.
    J Endourol; 2021 May; 35(5):687-694. PubMed ID: 33050741
    [Abstract] [Full Text] [Related]

  • 14. Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones.
    Prochaska M, Taylor E, Ferraro PM, Curhan G.
    J Urol; 2018 May; 199(5):1262-1266. PubMed ID: 29132983
    [Abstract] [Full Text] [Related]

  • 15. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
    Sriboonlue P, Prasongwattana V, Tungsanga K, Sitprija V.
    J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
    [Abstract] [Full Text] [Related]

  • 16. Reduced crystallization inhibition by urine from women with nephrolithiasis.
    Asplin JR, Parks JH, Nakagawa Y, Coe FL.
    Kidney Int; 2002 May; 61(5):1821-9. PubMed ID: 11967033
    [Abstract] [Full Text] [Related]

  • 17. Reduced crystallization inhibition by urine from men with nephrolithiasis.
    Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL.
    Kidney Int; 1999 Oct; 56(4):1505-16. PubMed ID: 10504502
    [Abstract] [Full Text] [Related]

  • 18. Calcium stone disease: a multiform reality.
    Trinchieri A, Castelnuovo C, Lizzano R, Zanetti G.
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [Abstract] [Full Text] [Related]

  • 19. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, Prabhakaran VM, Dow D, Colpitts A.
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [Abstract] [Full Text] [Related]

  • 20. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Asplin JR.
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.